 |
| Sophie Taylor-Roberts |
Sophie Taylor-Roberts, who most recently was managing director of Hill & Knowlton's UK healthcare unit, has joined Finn Partners to helm its British healthcare group.
She succeeds Julie Adrian, who returned to her role as head of Alverium Health.
At H&K, which WPP folded into Burson, Taylor-Roberts counseled GSK, Haleon, Takeda and Roche.
She has more than 20 years of healthcare PR experience, which includes stints at Good Relations and the Red Consultancy.
“Sophie brings an exceptional blend of strategic insight, leadership acumen and a proven track record of client successes,” said Fern Lazar, Finn’s managing partner and global health practice lead.
Gil Bashe, Finn’s chair of global health and purpose, said Taylor-Roberts’ “experience across the health industry spectrum—from pharma and biotech to healthtech to advocacy and access—equips our clients with the foresight and flexibility that health transformation needs to succeed.”
Finn ranked No. 6 in O’Dwyer’s healthcare rankings with 2024 fee income of $58M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
